USA flag logo/image

An Official Website of the United States Government

Company Information:

Company Name:
ZENOBIA THERAPEUTICS, INC
Address:
ZENOBIA THERAPEUTICS, INC
505 COAST BLVD S, STE 111
LA JOLLA, CA 92037 4614
Phone:
N/A
URL:
N/A
EIN:
126272670
DUNS:
826998291
Number of Employees:
N/A
Woman-Owned?:
Yes
Minority-Owned?:
No
HUBZone-Owned?:
No

Commercialization:

Has been acquired/merged with?:
N/A
Has had Spin-off?:
N/A
Has Had IPO?:
N/A
Year of IPO:
N/A
Has Patents?:
N/A
Number of Patents:
N/A
Total Sales to Date $:
$ 0.00
Total Investment to Date $
$ 0.00
POC Title:
N/A
POC Name:
N/A
POC Phone:
N/A
POC Email:
N/A
Narrative:
N/A

Award Totals:

Program/Phase Award Amount ($) Number of Awards
SBIR Phase I $785,128.00 2

Award List:

Discovery of inhibitors of ALK for the treatment of cancer

Award Year / Program / Phase:
2009 / SBIR / Phase I
Award Amount:
$328,829.00
Agency:
HHS
Principal Investigator:
Vicki Nienaber
Abstract:
DESCRIPTION (provided by applicant): Our aim is to discover novel safety assessment candidates (pre-clinical compounds) for the treatment of cancer by targeting the receptor tyrosine kinase (RTK), anaplastic lymphoma kinase (ALK). It is now proven that ALK has a widespread pathogenic involvement in… More

Discovery of inhibitors of the lipopolysaccharide synthesis pathway enzymes LpxA

Award Year / Program / Phase:
2010 / SBIR / Phase I
Award Amount:
$456,299.00
Agency:
HHS
Principal Investigator:
Vicki Nienaber
Abstract:
DESCRIPTION (provided by applicant): Bacterial resistance to antibiotics has been an evolving problem since the dawn of the antibiotics era, requiring consistent scientific advances over the years in antibiotic discovery, epidemiological surveillance and i nfection control techniques to overcome the… More